Actif8 hical®

Actif8 hical®
Product Description

Innophos manufactures specialty grade phosphate products which includes actif8 hical®. It s a formulated mixture of food grade sodium aluminum phosphate, acidic (LEVAIR®) and food grade anhydrous monocalcium phosphate (V-90®). It is a white, free-flowing powder having a minimum calcium content of approximately 11.4%. Contact us for more information.

Innophos Inc.

  • US
  • 2015
    On CPHI since

Innophos Inc.

  • US
  • 2015
    On CPHI since

More Products from Innophos Inc. (4)

  • A-Tab® MD

    Product A-Tab® MD

    A-Tab® MD is a multi-functional co-processed excipient specially formulated to enhance compressibility and simplify formulations in pharmaceutical and nutraceutical tablets.
  • Actif8®

    Product Actif8®

    Innophos manufactures specialty grade phosphate products which includes actif8®. It is a formulated mixture of food grade sodium aluminum phosphate, acidic (LEVAIR®) and food grade anhydrous monocalcium phosphate (V-90®). It is a white, free-flowing powder having a calcium content of approximately 6.2%.. C...
  • Ajax - monocalcium phosphate monohydrate granular®

    Product Ajax - monocalcium phosphate monohydrate granular®

    Innophos manufactures specialty grade phosphate products which includes ajax - monocalcium phosphate monohydrate granular®. It is is a brilliant white, free-flowing crystalline material which complies with the specifications of the Food Chemicals Codex (current edition)®. Contact us for more information.
  • Bac n fos®

    Product Bac n fos®

    Innophos manufactures specialty grade phosphate products which includes bac n fos®. It is a white powder that is essentially free of lumps, foreign matter, and odor. Contact us for more information.

Innophos Inc. resources (3)

  • News A-TAB® MD Shines in New Compressibility Study

    Author:  Vinit Nigudkar, Global Technical Services & Application Development, Innophos
  • Whitepaper Co-Processed Multifunctional Excipients in Tableting

    The global dietary supplement industry is experiencing unprecedented growth in product development from existing players as well as new entrants. To gain a competitive edge, many supplement makers formulate with multiple ingredients, including minerals, amino acids, herbals, and vitamins in a single tablet. Doing so allows these companies to position their products with additional benefits compared to other delivery systems in the same category. However, multi-ingredient formulations also create marketing and operational challenges for manufacturers.

    A trend dominating the supplement market is the clean label movement. This trend is increasing pressure on manufacturers to simplify labels by reducing the number of ingredients. Additionally, consumers desire smaller, easier-to-swallow tablets for children and senior citizens.

    To meet these consumer trends, dietary supplement manufacturers should consider CPMEs as a key solution.

    In this paper you will learn:
    What CPMEs are
    Advantages of CPMEs
    How CPMEs enable manufacturers to reduce ingredients
    Why CPMEs deliver more in a smaller pill
    Comparison of Innophos CPMEs vs. conventional excipients
  • Video Novel Excipients

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Innovation in excipients encourages the development of advanced treatments and therapeutics and increases access to high-quality, effective, and safe medicines. This session provides an overview on the actual landscape, offers some examples and tackles some of the challenges and opportunities in this field. The role of Excipients in supporting innovation and development Challenges in identifying Novel Excipients today Barriers & potential solutionsfor facilitating the use of Novel Excipients Multifunctional coprocessed excipients for improved tabletting performance The Importance of excipient quality: GMPs and evolving regulations